Altered regulation of negative affect in patients with fibromyalgia: A diary study.


Journal

European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774

Informations de publication

Date de publication:
03 2021
Historique:
received: 24 04 2020
revised: 19 10 2020
accepted: 22 11 2020
pubmed: 2 12 2020
medline: 28 4 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

Fibromyalgia is characterized by widespread musculoskeletal pain and often accompanied by cognitive and emotional problems. Adaptation to fibromyalgia may therefore also rely on one's ability to regulate emotional problems. In this study, we examined two indices of emotion regulation, that is, (a) affective instability, involving frequent large fluctuations in self-reported affect, and (b) resting heart rate variability (HRV). Participants were 46 patients with fibromyalgia (M Results indicate increased levels of NA instability and reduced levels of HRV in patients with fibromyalgia in comparison with healthy controls. Furthermore, HRV and NA instability were inversely related. Finally, in patients, higher NA instability was related to increased pain disability. Current findings support the idea that patients with fibromyalgia are confronted with fluctuating emotions. These results may have important implications for treatment as they provide support for the use of emotion regulation skills training in patients with fibromyalgia to impact upon NA instability. This study provides novel insight in the link between emotion regulation indices,that is, heart-rate variability and negative affective (NA) instability, in patients with fibromyalgia, and presents evidence for differences in both emotion regulation indices between patients with fibromyalgia and healthy people. Furthermore, results link increased NA instability with increased levels of daily disability in patients with fibromyalgia. Together, these findings offer support for a key role of emotion regulation in fibromyalgia outcomes, providing pathways for clinical practice.

Sections du résumé

BACKGROUND
Fibromyalgia is characterized by widespread musculoskeletal pain and often accompanied by cognitive and emotional problems. Adaptation to fibromyalgia may therefore also rely on one's ability to regulate emotional problems. In this study, we examined two indices of emotion regulation, that is, (a) affective instability, involving frequent large fluctuations in self-reported affect, and (b) resting heart rate variability (HRV).
METHODS
Participants were 46 patients with fibromyalgia (M
RESULTS
Results indicate increased levels of NA instability and reduced levels of HRV in patients with fibromyalgia in comparison with healthy controls. Furthermore, HRV and NA instability were inversely related. Finally, in patients, higher NA instability was related to increased pain disability.
CONCLUSIONS
Current findings support the idea that patients with fibromyalgia are confronted with fluctuating emotions. These results may have important implications for treatment as they provide support for the use of emotion regulation skills training in patients with fibromyalgia to impact upon NA instability.
SIGNIFICANCE
This study provides novel insight in the link between emotion regulation indices,that is, heart-rate variability and negative affective (NA) instability, in patients with fibromyalgia, and presents evidence for differences in both emotion regulation indices between patients with fibromyalgia and healthy people. Furthermore, results link increased NA instability with increased levels of daily disability in patients with fibromyalgia. Together, these findings offer support for a key role of emotion regulation in fibromyalgia outcomes, providing pathways for clinical practice.

Identifiants

pubmed: 33259659
doi: 10.1002/ejp.1706
pmc: PMC7984394
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

714-724

Informations de copyright

© 2020 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC®.

Références

Neurosci Biobehav Rev. 2017 Mar;74(Pt A):233-255
pubmed: 28057463
Psychol Bull. 2015 Jul;141(4):901-30
pubmed: 25822133
Pain. 2016 Aug;157(8):1783-1790
pubmed: 27075427
Pain. 2018 Feb;159(2):342-350
pubmed: 29140926
Pain. 2013 Mar;154(3):468-475
pubmed: 23375161
Eur J Pain. 2021 Mar;25(3):714-724
pubmed: 33259659
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
Psychol Methods. 2008 Dec;13(4):354-75
pubmed: 19071999
Psychophysiology. 2012 May;49(5):672-82
pubmed: 22335779
J Abnorm Psychol. 2009 Feb;118(1):195-202
pubmed: 19222325
J Appl Psychol. 2012 Sep;97(5):951-66
pubmed: 22582726
Psychother Psychosom. 2007;76(4):226-33
pubmed: 17570961
Psychol Bull. 1999 Jan;125(1):3-30
pubmed: 9990843
J Psychosom Res. 2010 Jan;68(1):29-36
pubmed: 20004298
Behav Res Methods. 2011 Dec;43(4):1161-70
pubmed: 21573720
J Abnorm Psychol. 2008 Aug;117(3):647-61
pubmed: 18729616
Cogn Emot. 2015;29(6):1026-41
pubmed: 25310694
Pain. 2007 Dec 5;132(3):233-236
pubmed: 17961924
Clin J Pain. 2016 Mar;32(3):218-25
pubmed: 25924095
Behav Res Ther. 1999 Feb;37(2):167-82
pubmed: 9990748
Glob Qual Nurs Res. 2016 Jul 6;3:2333393616658141
pubmed: 28620627
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Arch Phys Med Rehabil. 1994 Oct;75(10):1082-6
pubmed: 7944912
Eur Heart J. 1996 Mar;17(3):354-81
pubmed: 8737210
J Abnorm Psychol. 2012 Nov;121(4):819-29
pubmed: 22708886
Pain. 2016 Jan;157(1):7-29
pubmed: 26431423
PLoS One. 2013 Nov 29;8(11):e81536
pubmed: 24312315
Ann Behav Med. 2005 Jun;29(3):216-24
pubmed: 15946116
J Psychosom Res. 2018 Apr;107:38-45
pubmed: 29502762
Pain. 1985 Dec;23(4):345-356
pubmed: 4088697
Neurosci Biobehav Rev. 2009 Feb;33(2):81-8
pubmed: 18771686
Pain. 2010 Oct;151(1):37-44
pubmed: 20561749
Ann Behav Med. 2009 Apr;37(2):173-83
pubmed: 19357933
J Abnorm Psychol. 2007 Aug;116(3):578-88
pubmed: 17696713
J Appl Biobehav Res. 2013 Jun;18(2):82-103
pubmed: 24143062
Pain. 2008 Jan;134(1-2):158-73
pubmed: 17532138
Percept Mot Skills. 1984 Dec;59(3):974
pubmed: 6240632
Psychol Methods. 2007 Jun;12(2):121-38
pubmed: 17563168
Cogn Behav Ther. 2013;42(3):215-23
pubmed: 23978106
J Affect Disord. 2000 Dec;61(3):201-16
pubmed: 11163422

Auteurs

Silke Rost (S)

Department of Behavioural and Cognitive Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Department of Experimental-Clinical and Health Psychology, Ghent University, Belgium.

Geert Crombez (G)

Department of Experimental-Clinical and Health Psychology, Ghent University, Belgium.

Stefan Sütterlin (S)

Faculty for Health and Welfare Sciences, Østfold University College, Halden, Norway.
Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.

Claus Vögele (C)

Department of Behavioural and Cognitive Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Research Group Health Psychology, University of Leuven, Belgium.

Elke Veirman (E)

Department of Experimental-Clinical and Health Psychology, Ghent University, Belgium.

Dimitri M L Van Ryckeghem (DML)

Department of Behavioural and Cognitive Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Department of Experimental-Clinical and Health Psychology, Ghent University, Belgium.
Department of Clinical Psychological Science, Maastricht University, Maastricht, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH